A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC#681239, NSC#724772) for Patients with High Allelic Ratio FLT3/ITD

Submitted by centretek on Sat, 10/15/2022 - 10:29

Source URL

https://www.inova.org/clinical-trials/phase-3-randomized-trial-patients-de-novo-aml-using-bortezomib-and-sorafenib

Description

General Information Age Group Pediatrics/Children Status Active Protocol Number AAML1031 Offered At Inova Children's Hospital 3300 Gallows Road Falls Church, VA 22042 Contact Information Contact Name Keary Jane't Contact Phone 703-776-3456 Contact Email Send Email

Clinical Trials Category

Cancer

Clinical Trials Sub categories

Leukemia

Crawled Content Type

Clinical Trials